Table 1 |.
Brain pathology associated with the three Alzheimer disease variants
| Pathology | Feature | Alzheimer disease variant | ||
|---|---|---|---|---|
| Autosomal dominant | APOE ε4 sporadic | Non-APOE ε4 sporadic | ||
| Aβ | Global burden | +++97,98 | ++117,118 | +117,118 |
| Topography | Precuneus; isthmus of cingulate gyrus, posterior cingulate and anterior cingulate gyri; rostral middle frontal gyrus, pars opercularis and pars triangularis of inferior frontal gyrus; orbital frontal gyrus; paracentral gyrus; postcentral gyrus; lateral temporal gyrus; lateral parietal gyrus; lateral occipital and pericalcarine gyri; and caudate nucleus81,89,90 | Precuneus; isthmus of cingulate gyrus, posterior cingulate and anterior cingulate gyri; medial and lateral orbitofrontal gyrus; rostral middle frontal and superior frontal gyri; and paracentral gyrus113,117 | Precuneus; isthmus of cingulate gyrus, posterior cingulate and anterior cingulate gyri; medial and lateral orbitofrontal gyri; paracentral gyrus; superior parietal lobe; and supramarginal gyrus113,117 | |
| Tau | Global burden | +++91 | ++126 | +++126 |
| Topography | Precuneus; isthmus of cingulate gyrus and posterior cingulate gyrus; middle and inferior frontal gyri; medial and lateral temporal gyri; lateral parietal lobe; lateral occipital lobe91 | Precuneus; isthmus of cingulate gyrus and posterior cingulate gyrus; middle frontal gyrus; medial, middle and inferior temporal gyri; lateral parietal lobe; lateral occipital lobe124,126–128 | Precuneus; isthmus of cingulate gyrus and posterior cingulate gyrus; superior, middle and inferior frontal gyri; medial, middle and inferior temporal gyri; lateral parietal lobe; lateral occipital lobe124,126–128 | |
| TDP43 | Global burden | Variable: −/+93,94 | ++130 | +130 |
| Topography | Hippocampus and amygdala93 | Amygdala, hippocampus, medial frontal gyrus130 | ||
| α-Synuclein | Global burden | Variable: −/+/++94–96 | ++131 | +131 |
| Topography | Amygdala96 | Not reported | Not reported | |
| Cerebral amyloid angiopathy | Global burden | +++97,98 | +++119 | +119 |
| Topography | Type 1 or type 2 (REF.17) | Type 1 (REFS120–123) | Type 2 (REFS120–123) | |
| Neuroinflammation | Topography | Colocalized with tau and Aβ pathology99 | Colocalized with tau and Aβ pathology99,167–170 | Weaker colocalization with tau and Aβ pathology99,167–170 |
| Neurodegeneration | Global burden | +++12 | +126 | ++126 |
| Topography | Precuneus; pars opercularis of inferior frontal gyrus; medial, superior and middle temporal gyri; lateral parietal lobe; lateral occipital lobe81,90,92 | Precuneus; isthmus of cingulate gyrus and posterior cingulate gyrus; medial, superior, and middle temporal gyri; temporoparietal junction125–127,129 | Precuneus; isthmus of cingulate gyrus and posterior cingulate gyrus; superior, middle and inferior frontal gyri; medial, superior and middle temporal gyri; temporoparietal junction; parietal lobe125–127,129 | |
The number of plus signs reflects the global burden of brain pathology based on studies comparing autosomal dominant Alzheimer disease (AD) with sporadic AD, and APOE ε4-related sporadic variants with APOE ε4-unrelated sporadic variants. Head-to-head comparisons among autosomal dominant AD, APOE ε4-related AD and APOE ε4-unrelated sporadic AD are not available. Global burden: +, low; ++, intermediate; +++, high. Regions listed under ‘topography’ are those mainly affected by pathology. Cerebral amyloid angiopathy type 1 is with capillary involvement, whereas type 2 is without capillary involvement. The topography of Aβ, tau and neurodegeneration and their burden are graphically represented in FIG. 1. Aβ, amyloid-β; TDP43, TAR DNA-binding protein 43.